रोसरी बायोटेक शेयर की कीमत

Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

• बीएसई इंडिया
• 2 दिन 21 घंटे पहले

Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20, 2026.

• बीएसई इंडिया
• 1 सप्ताह 5 दिन पहले

<h3><strong><span style="font-size:16px;">स्पेशलिटी केमिकल्स कंपनी रोसरी बायोटेक ने Q1FY27 परिणामों की घोषणा की</span></strong></h3><p _ngcontent-ng-c1517154722=""><strong _ngcontent-ng-c1517154722="">कंसोलिडेटेड फाइनेंशियल हाइलाइट्स:</strong></p><ul><li _ngcontent-ng-c1517154722="">Revenue from Operations: Consolidated revenue for Q1FY27 stood at Rs 6,972.00 million, representing a YoY growth of 28.23% compared to Rs 5,437.16 million in Q1FY26, and a QoQ growth of 1.80% compared to Rs 6,848.62 million in Q4FY26.</li><li _ngcontent-ng-c1517154722="">Total Income: The company reported a total consolidated income of Rs 7,003.87 million in Q1FY27, which is an increase of 28.53% YoY from Rs 5,449.16 million in Q1FY26, but a slight decrease of 0.50% QoQ from Rs 7,039.27 million in Q4FY26.</li><li _ngcontent-ng-c1517154722="">Profit After Tax (PAT): Consolidated profit for Q1FY27 was Rs 350.95 million, a YoY growth of 4.46% over Rs 335.96 million in Q1FY26, but a QoQ decline of 23.65% compared to Rs 459.67 million in Q4FY26.</li><li _ngcontent-ng-c1517154722="">Earnings Per Share (EPS): Consolidated basic EPS for Q1FY27 was Rs 6.34, compared to Rs 6.07 in Q1FY26 and Rs 8.30 in Q4FY26.</li></ul><p _ngcontent-ng-c1517154722=""><strong _ngcontent-ng-c1517154722="">स्टैंडअलोन फाइनेंशियल हाइलाइट्स:</strong></p><ul><li _ngcontent-ng-c1517154722="">Revenue from Operations: Standalone revenue for Q1FY27 reached Rs 4,822.75 million, up 31.86% YoY from Rs 3,657.58 million in Q1FY26, though it declined 6.56% QoQ from Rs 5,161.38 million in Q4FY26.</li><li _ngcontent-ng-c1517154722="">Total Income: Total standalone income for Q1FY27 was Rs 4,844.63 million, marking a YoY growth of 31.83% from Rs 3,675.00 million in Q1FY26, while decreasing 10.10% QoQ from Rs 5,388.67 million in Q4FY26.</li><li _ngcontent-ng-c1517154722="">Profit After Tax (PAT): Standalone PAT for Q1FY27 stood at Rs 342.66 million, reflecting a YoY growth of 30.62% from Rs 262.33 million in Q1FY26, but a QoQ decrease of 37.39% from Rs 547.30 million in Q4FY26.</li><li _ngcontent-ng-c1517154722="">प्रति शेयर आय (EPS): Q1FY27 के लिए स्टैंडअलोन बेसिक EPS ₹ 6.19 था, Q1FY26 में ₹ 5.85 और Q4FY26 में ₹ 9.88 की तुलना में.</li></ul><p _ngcontent-ng-c1517154722=""><strong _ngcontent-ng-c1517154722="">बिज़नेस हाइलाइट्स:</strong></p><ul><li _ngcontent-ng-c1517154722="">ESOP Grants and Allotments: The Board approved the grant of 4,000 stock options under the Rossari Employee Stock Option Plan - 2019 (ESOP 2019). During Q1FY27, the company allotted 8,250 equity shares of Rs 2 each pursuant to the exercise of options under the approved plan.</li><li _ngcontent-ng-c1517154722="">Internal Restructuring: The Board approved the transfer of 100% shareholding in Rossari International Limited Company (RILC), a wholly-owned subsidiary, to Rossari (Singapore) Pte. Ltd. (Rossari Singapore), which is also a wholly-owned subsidiary of the company.</li><li _ngcontent-ng-c1517154722="">Verbatim Commentary on Restructuring: "The proposed transfer is undertaken as part of an internal group restructuring exercise aimed at bringing all overseas subsidiaries of the Company under a single, existing overseas investment subsidiary, thereby establishing a common holding platform. The restructuring is intended to simplify overseas regulatory reporting into a single reporting line."</li><li _ngcontent-ng-c1517154722="">Consideration of Restructuring: The proposed consideration for the sale of 9,000 shares of RILC to Rossari Singapore is approximately Rs 24 crore.</li><li _ngcontent-ng-c1517154722="">Equity Share Capital: Following allotments during the quarter, the issued and paid-up equity share capital of the company increased to Rs 11,07,88,232, consisting of 5,53,94,116 equity shares of Rs 2 each.</li></ul><p><strong>Edward Menezes, Promoter & Executive Chairman, & Sunil Chari, Promoter & Managing Director, said:</strong> “We commenced FY27 on a strong note, delivering robust consolidated revenue growth of 28% YoY. The performance was driven by healthy momentum in the domestic business and the continued expansion of our international presence. Despite a dynamic operating environment, our diversified business model, broad-based market presence and disciplined execution enabled us to deliver growth across all our business segments.</p><p>Our HPPC, TSC and AHN businesses delivered YoY growth of 28%, 28% and 27%, respectively, reflecting healthy momentum across the portfolio. Performance was supported by deeper market penetration, expansion into new applications and a higher contribution from differentiated, value-added specialty solutions across end-user industries.</p><p>Our international business continued to make steady progress, supported by higher wallet share with global partners and growing acceptance of our specialty solutions across key overseas markets. During the quarter, we further strengthened our regional presence with the establishment of a greenfield blending facility in Thailand, designed to serve Southeast Asia. The facility will enhance our ability to offer customised formulations, respond swiftly to local market requirements and improve supply-chain efficiency.</p><p>Over the past few years, we have made focused investments in developing new capabilities, innovation and product development. Capacity utilisation across these investments has been improving steadily, and our priority is now to drive optimal utilisation, strengthen the product portfolio and enhance operational efficiencies. Together with our robust R&D platform, these efforts will enable us to address evolving industry requirements and reinforce our competitive positioning.</p><p>As we progress through FY27, we remain focused on disciplined execution, innovation and profitable growth. Supported by a healthy balance sheet, an integrated manufacturing platform and an expanding global presence, we are well-positioned to capitalise on emerging opportunities and create sustainable long-term value for all our stakeholders.”</p><p><a class="lb" href="/hindi/get-document/post/pdf/5736309/" target="_blank">परिणाम PDF</a></p>

• ट्रेंडलाइन
• 2 सप्ताह 3 दिन पहले